メタ情報
| meta description平均長 | 55 |
|---|
| OGPありページ数 | 19 |
|---|
| Twitterカードありページ数 | 0 |
|---|
HTML言語 分布
| キー | 割合 |
|---|
| zh-hant | 52.63% |
| en | 47.37% |
内部リンク分析（Internal）
| ユニーク内部リンク数 | 62 |
|---|
| ページあたり内部リンク平均 | 18.68 |
|---|
連絡先候補（Contacts）
このデータの閲覧には会員登録が必要になります。会員登録
キーワード分析（KeywordMap）
ワードクラウド上位
| 語 | 重み |
|---|
| Roche | 1 |
| COVID | 0.911765 |
| test | 0.676471 |
| tests | 0.470588 |
| SARS | 0.441176 |
| CoV | 0.441176 |
| Test | 0.382353 |
| help | 0.382353 |
| can | 0.339321 |
| healthcare | 0.323529 |
| has | 0.318113 |
| food | 0.296906 |
| testing | 0.294118 |
| antigen | 0.294118 |
| FDA | 0.264706 |
| rapid | 0.264706 |
| use | 0.264706 |
| safety | 0.254491 |
| high | 0.235294 |
| pandemic | 0.235294 |
| virus | 0.235294 |
| diagnostics | 0.235294 |
| patients | 0.233283 |
| diagnosis | 0.229718 |
| have | 0.212076 |
| support | 0.205882 |
| care | 0.205882 |
| EUA | 0.176471 |
| individuals | 0.176471 |
| results | 0.176471 |
| Biosensor | 0.176471 |
| more | 0.176471 |
| been | 0.176471 |
| solutions | 0.16966 |
| global | 0.16966 |
| molecular | 0.164084 |
| cancer | 0.148453 |
| world | 0.147676 |
| sample | 0.147059 |
| years | 0.147059 |
| including | 0.147059 |
| Rapid | 0.147059 |
| response | 0.147059 |
| who | 0.147059 |
| portfolio | 0.147059 |
| detect | 0.147059 |
| working | 0.147059 |
| company | 0.143037 |
| also | 0.130034 |
| detection | 0.127245 |
共起語上位
| 語1 | 語2 | スコア | 共起ページ数 |
|---|
| CoV | SARS | 3.655004 | 61 |
| food | safety | 2.823903 | 41 |
| customer | demand | 2.395573 | 13 |
| Emergency | Use | 2.34642 | 12 |
| Authorization | Use | 2.34642 | 12 |
| anterior | nasal | 2.34642 | 12 |
| nasal | swab | 2.34642 | 12 |
| against | fight | 2.34642 | 12 |
| Actemra | RoActemra | 2.34642 | 12 |
| Biotech | Genconn | 2.257144 | 12 |
| aged | years | 2.231277 | 13 |
| actively | engaging | 2.205553 | 12 |
| Drug | Food | 2.205553 | 12 |
| States | United | 2.205553 | 12 |
| please | visit | 2.205553 | 12 |
| high | quality | 2.18111 | 16 |
| CHF | billion | 2.105513 | 8 |
| older | years | 2.096288 | 12 |
| Health | World | 2.096288 | 12 |
| Health | Organization | 2.096288 | 12 |
| accurate | reliable | 2.064686 | 12 |
| 匯聚全球各國跨領域菁英 | 及產 | 2.064493 | 8 |
| 依客戶需求整合資源提供服務項目 | 技術研發 | 2.064493 | 8 |
| convergence | multi | 2.064493 | 8 |
| CAP | CLIA | 2.064493 | 8 |
| 及產 | 研人才與創新力量 | 2.023474 | 8 |
| 研人才與創新力量 | 積極與國際生技大廠合作與交流 | 2.023474 | 8 |
| 引進全球高端檢測平台 | 積極與國際生技大廠合作與交流 | 2.023474 | 8 |
| 引進全球高端檢測平台 | 殷盼台灣分子診斷技術與世界先進大國同步 | 2.023474 | 8 |
| 以台灣為基地 | 殷盼台灣分子診斷技術與世界先進大國同步 | 2.023474 | 8 |
| 以台灣為基地 | 致力發展癌症的診斷與預防兩大領域 | 2.023474 | 8 |
| 串聯母公司康聯生醫專業資源與服務鏈 | 致力發展癌症的診斷與預防兩大領域 | 2.023474 | 8 |
| 串聯母公司康聯生醫專業資源與服務鏈 | 從個人獨特的基因 | 2.023474 | 8 |
| 從個人獨特的基因 | 環境以及生活方式的數據密碼 | 2.023474 | 8 |
| 環境以及生活方式的數據密碼 | 發展精準個人化醫療標準 | 2.023474 | 8 |
| 依客戶需求整合資源提供服務項目 | 發展精準個人化醫療標準 | 2.023474 | 8 |
| disciplinary | multi | 2.023474 | 8 |
| disciplinary | talents | 2.023474 | 8 |
| institutes | power | 2.023474 | 8 |
| innovation | power | 2.023474 | 8 |
| Taking | foothold | 2.023474 | 8 |
| dedicated | ourselves | 2.023474 | 8 |
| Synergy | cancers | 2.023474 | 8 |
| chain | parent | 2.023474 | 8 |
| Based | individual | 2.023474 | 8 |
| personalized | precision | 2.023474 | 8 |
| Integrate | resources | 2.023474 | 8 |
| activities | education | 2.023474 | 8 |
| NAVIFY | Pass | 2.023474 | 8 |
| nucleocapsid | protein | 2.023474 | 8 |